Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Renal and cardiovascular role of the neuropeptide Y Y1 receptor in ischaemic heart failure rats

Research output: Contribution to journalJournal articleResearchpeer-review

  1. In vivo PET Imaging of [11C]CIMBI-5, a 5-HT2AR Agonist Radiotracer in Nonhuman Primates

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Ovariectomy reduces vasocontractile responses of rat middle cerebral arteries after focal cerebral ischemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hormonal influences in migraine - interactions of oestrogen, oxytocin and CGRP

    Research output: Contribution to journalReviewResearchpeer-review

  3. CGRP and migraine; from bench to bedside

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The cardiovascular role of the neuropeptide Y Y1 receptors in-vivo and in-vitro in ischaemic heart failure was evaluated by using the novel neuropeptide Y Y1 selective antagonist BIBP 3226 (R-N2-(diphenylacetyl)-N-[(4-hydroxyphenyl)methyl]-D-arginine-amid e). In pithed rats, incremental doses of BIBP 3226 inhibited the exogenous neuropeptide Y induced pressor response in a dose-related fashion and a bolus injection of BIBP 3226 (0.5 mg kg(-1)) significantly shifted the pressor response curve of exogenous neuropeptide Y to the right. The potentiation effect to exogenous neuropeptide Y on the pressor response to preganglionic sympathetic nerve stimulation in ischaemic heart failure rats as well as on the contractile response to noradrenaline in renal arteries in sham-operated animals were also inhibited by the neuropeptide Y Y1 antagonist. In conscious ischaemic heart failure rats, incremental doses of BIBP 3226 (0.125-1 mg kg(-1)) significantly reduced basal blood pressure and heart rate. Compared with sham-operated rats, neuropeptide Y by itself induced no contraction and no potentiation on noradrenaline elicited contraction in renal artery of the ischaemic heart failure rat. Furthermore, under in-vivo conditions, BIBP 3226 did not influence basal renal function or the response to exogenous neuropeptide Y on urinary volume, urinary sodium and urinary potassium. Our results demonstrate that although there is a downregulation of the Y1 receptors by ischaemic heart failure, Y1 receptors are still mainly involved in cardiovascular actions of exogenous neuropeptide Y and play a role in maintaining basal blood pressure and heart rate in ischaemic heart failure. However, our data do not imply any significant role of Y1 receptors on basal renal function in the ischaemic heart failure rat model.

Original languageEnglish
JournalJournal of Pharmacy and Pharmacology
Volume51
Issue number11
Pages (from-to)1257-65
Number of pages9
ISSN0022-3573
Publication statusPublished - Nov 1999
Externally publishedYes

    Research areas

  • Animals, Arginine, Blood Pressure, Cardiovascular System, Decerebrate State, Dose-Response Relationship, Drug, Heart Rate, Hemodynamics, In Vitro Techniques, Kidney, Male, Myocardial Ischemia, Neuropeptide Y, Norepinephrine, Potassium, Rats, Rats, Sprague-Dawley, Receptors, Neuropeptide Y, Renal Artery, Sodium

ID: 45646103